You searched for Antibody candidate - Page 16 of 69

News and Trends 5 Oct 2016

New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira

…Figure 1. Psoriasis can appear in multiple parts of the body and cause intense pain. The new candidate, guselkumab, is a fully human monoclonal antibody against interleukin-23 that is delivered…

October 5, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 Sep 2017

FREE TICKET Giveaway – European Antibody Congress

Our wonderful readers now have the chance to win a FREE ticket for the European Antibody Congress in Basel, Switzerland! On 31st October – 2nd November you will have the…

September 5, 2017 - 2 minutesmins - By External Contributor

News and Trends 30 Jun 2020

Kymab Wins UK Supreme Court Antibody Battle Against Regeneron

The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody drug patents held by US giant Regeneron, a decision that could make it harder for…

June 30, 2020 - 4 minutesmins - By Anita Chakraverty

News and Trends 30 Jan 2018

Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic

Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid tumors. Innate Pharma uses antibodies to enhance the immune…

January 30, 2018 - 3 minutesmins - By Alex Dale

News and Trends 25 Sep 2017

Sanofi ‘Super-Antibody’ HIV Treatment Kills the Majority of Virus Strains

…powerful ‘tri-specific antibody’. Structure of the HIV virus. Sanofi’s tri-antibody treatment targets the synthesis of the phospholipid envelope. Current treatments are based on the use of antiretroviral therapy (ART), which…

September 25, 2017 - 3 minutesmins - By Alex Dale

News and Trends 26 Oct 2022

Scancell signs agreement with Genmab

…commercialize a Scancell investigational anti-glycan monoclonal antibody into novel therapeutic products. Genmab has been granted the exclusive right to develop and commercialize the Scancell antibody in multiple novel potential therapeutic…

October 26, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 16 Nov 2016

New Private Placement to Boost the Profitable Therapeutic Antibody Market

MorphoSys has announced a private placement of shares to raise funds for its antibody therapy programs. With this push, the company is solidifying its position as a leader in the…

November 16, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

sanofi biomunex cancer therapy bispecific antibodies 1

News and Trends 15 Jan 2019

Sanofi Obtains License for French Company’s Antibody Engineering Platform

…lead antibody is due to enter the clinic next year for the treatment of solid tumors. The company’s second lead candidate is aimed at blood cancers such as multiple myeloma,…

January 15, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 6 Nov 2017

German Biotech Teams Up with BioNTech to Boost Antibody Development

MAB Discovery and BioNTech are working together to push through the development of new antibody therapeutics using MAB’s technology platform. MAB Discovery creates monoclonal antibodies by stimulating natural antibody maturation…

November 6, 2017 - 1 minutemin - By Alex Dale

Best in Biotech 20 Feb 2018

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

…core focus is the discovery and development of new antibody-based drugs for the treatment of cancer, immune disorders, and inflammatory diseases. Novimmune’s innovation lies in their monoclonal and bispecific antibody…

February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 22 Jul 2016

German Biotech raises extra €31M to get first-in-class Antibody through trials

InflaRx, a German-based biopharma, has raised €31M in a series C fundraising. This is to further advance a potentially first-in-class antibody which targets an acute form of self-inflammation. Based in…

July 22, 2016 - 2 minutesmins - By Dani Bancroft

covid 19 vaccines adenovirus adenoviral vector

News and Trends 8 Jun 2022

New COVID antibody cocktail developed

…in live virus neutralization assays. The cocktail and each antibody also outperformed other monoclonal treatments currently approved or authorized by the FDA and EMA, particularly against Omicron. “Antibody cocktails will…

June 8, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira

FREE TICKET Giveaway – European Antibody Congress

Kymab Wins UK Supreme Court Antibody Battle Against Regeneron

Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic

Sanofi ‘Super-Antibody’ HIV Treatment Kills the Majority of Virus Strains

Scancell signs agreement with Genmab

New Private Placement to Boost the Profitable Therapeutic Antibody Market

Sanofi Obtains License for French Company’s Antibody Engineering Platform

German Biotech Teams Up with BioNTech to Boost Antibody Development

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

German Biotech raises extra €31M to get first-in-class Antibody through trials

New COVID antibody cocktail developed

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!